Boston Scientific acquires Penumbra

Boston Scientific agreed to acquire Penumbra. Reported deal value: $14.5B. Status: Announced. Sector: Medical Devices. Target headquarters context: Alameda, California, United States.

This page summarizes publicly available information about the transaction as of 2026-01-19. Figures and status may change as filings and press coverage update.

Manufacturing Group Published January 19, 2026 Boston Scientific Corp . and Penumbra , Inc. have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock transaction that values Penumbra at $374 per share, reflecting an enterprise value of approximately $14.5 billion